| 摘要 |
The present invention provides improved methods, kits, and pharmaceutical compositions for treating or preventing diabetic complications by administering an effective amount of angiotensinogen, angiotensin I (AI), AI analogues, AI fragments and analogues thereof, angiotensin II (AII) analogues, AII fragments or analogues thereof or AII AT2 type 2 receptor agonists to treat or prevent diabetic complications. |
